Join ECHO Jan 31st for a webinar in their Lessons from Leaders series!

This session will feature Professor Steffen-Sebastian Bolz, who will provide an overview of Qanatpharma, its technologies and the story behind its success.

Qanatpharma is a Swiss and Toronto-based company specializing in microvascular research and medicine. Qanatpharma focuses on mechanisms related to the regulation of blood flow in the cerebral and peripheral microvasculature and has built a portfolio of treatment targets with potential applications in several diseases where microvascular dysfunction is a central feature in the pathology.